Neoadjuvant immunotherapy combined with chemotherapy in the treatment of stage III lung squamous cell carcinoma: a retrospective cohort study

BACKGROUND: Neoadjuvant immunochemotherapy has been proven to be a successful therapeutic strategy for patients with locally advanced non-small cell lung cancer (NSCLC). Nevertheless, there is a paucity of information regarding surgical feasibility and safety as well as tumor response. The present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jing, Lin, Shuai-Dong, Minervini, Fabrizio, Geraci, Travis C., Kim, Jae Jun, Tong, Chang-Yong, Li, Xin-Jian, Cao, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636463/
https://www.ncbi.nlm.nih.gov/pubmed/37969291
http://dx.doi.org/10.21037/jtd-23-1175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636463/
https://www.ncbi.nlm.nih.gov/pubmed/37969291
http://dx.doi.org/10.21037/jtd-23-1175

Ejemplares similares